ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TSVT 2seventy bio Inc

4.6699
-0.2601 (-5.28%)
Last Updated: 12:48:58
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
2seventy bio Inc TSVT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.2601 -5.28% 4.6699 12:48:58
Open Price Low Price High Price Close Price Previous Close
4.93 4.60 5.1299 4.93
more quote information »

Recent News

Date Time Source Heading
5/03/202406:00BW2seventy bio to Report First Quarter 2024 Financial Results..
4/05/202408:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
4/01/202406:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
3/20/202416:04BW2seventy bio Announces Appointments of Eli Casdin and..
3/15/202417:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
3/07/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202406:03EDGAR2Form 8-K - Current report
3/05/202406:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
3/01/202406:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
2/05/202415:05BW2seventy bio to Participate in Upcoming Investor Conferences
2/05/202406:02EDGAR2Form 8-K - Current report
2/05/202405:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
2/02/202415:54EDGAR2Form 8-K/A - Current report: [Amend]
1/30/202408:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
1/30/202406:48EDGAR2Form 8-K - Current report
1/30/202406:01BW2seventy bio Announces New Strategic Path Forward
1/05/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202306:25EDGAR2Form 8-K - Current report
12/11/202318:30BWAbecma Delivers Sustained Progression-Free Survival Versus..
12/11/202306:00BW2seventy bio to Host Investor Call at 8:00am ET on Tuesday,..
12/06/202313:00BW2seventy bio Reiterates Commitment to Maximizing Shareholder..
12/01/202305:49EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
12/01/202305:46EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
12/01/202305:43EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
12/01/202305:40EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/20/202313:31DJNTrending: Bristol Myers Squibb's Blood Cancer Treatment..
11/20/202307:30DJN2seventy Bio Shares Fall Premarket on Abecma Expansion Delay
11/20/202306:56DJNFDA Advisory Panel to Meet on Earlier Use of Abecma From..
11/20/202306:20EDGAR2Form 8-K - Current report
11/20/202305:59BWBristol Myers Squibb and 2seventy bio Provide Update on U.S...
11/14/202306:00BW2seventy bio Reports Third Quarter Financial Results and..
11/10/202306:00BW2seventy bio to Report Third Quarter 2023 Financial Results..
10/26/202306:05EDGAR2Form 8-K - Current report
9/13/202315:03EDGAR2Form 8-K - Current report
9/12/202306:13EDGAR2Form 8-K - Current report
9/12/202306:00BW2seventy bio Announces Strategic Restructuring to Prioritize..
9/12/202305:55BW2seventy bio and JW Therapeutics Announce Intent To Expand..
9/06/202315:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
9/06/202306:00BW2seventy bio to Participate in the 2023 Morgan Stanley..
8/16/202318:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202317:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/14/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202306:02EDGAR2Form 8-K - Current report
8/14/202306:00BW2seventy bio Reports Second Quarter Financial Results and..
8/08/202306:00BW2seventy bio to Report Second Quarter 2023 Financial Results..
8/01/202315:15BW2seventy bio to Participate in 2023 Wedbush PacGrow..
7/27/202308:16EDGAR2Form 8-K - Current report
6/14/202306:00BW2seventy bio Announces Clinical Study Pause of PLAT-08 Trial..
6/07/202306:00BW2seventy bio to Participate in Upcoming Investor Conference

Your Recent History

Delayed Upgrade Clock